Centrient Pharmaceuticals is the global business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals. They produce and sell intermediates and active pharmaceutical ingredients (APIs), as well as their own tablets, capsules and other finished dosage forms (FDFs).
Something looks off?